SCHEMBL19369167

SCHEMBL19369167

CC1CNCC(C)N1S(C)(=O)=O

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12583113 1.00 ACHE (0.56) ACHETP53
Hydrochloric Acid SCHEMBL15956512 0.98 ACHE (0.54) ACHETP53
SCHEMBL25154762 0.76 ACHE (0.35) ACHE
SCHEMBL25154773 0.76 ACHE (0.35) ACHE
SCHEMBL25154628 0.76 ACHE (0.35) ACHE
SCHEMBL25154641 0.76 ACHE (0.35) ACHE
SCHEMBL16943568 0.76 ACHE (0.80) ACHETP53
SCHEMBL29460270 0.73 ACHE (0.43) ACHE
SCHEMBL633200 0.73 ACHE (0.43) ACHE
SCHEMBL9321731 0.72 ACHE (1.00) ACHETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022086986-A1 TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH INHIBITORS OF MENIN KURA ONCOLOGY, INC. (US) 2022-04-28 WO disclosed
WO-2017161028-A1 SUBSTITUTED INHIBITORS OF MENIN-MLL AND METHODS OF USE KURA ONCOLOGY, INC. (US) 2017-09-21 WO disclosed